Fig. 1From: Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitorsStudy timeline diagram. Abbreviation: SGLT2i = sodium-glucose co-transporter-2 inhibitorBack to article page